Citigroup’s Vitamin Shoppe Inc. VSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,200
| Closed | -$67K | – | 7915 |
|
|
2019
Q3 | $67K | Buy |
10,200
+6,400
| +168% | +$36K | ﹤0.01% | 5949 |
|
|
2019
Q2 | $15K | Buy |
3,800
+1,100
| +41% | +$5.68K | ﹤0.01% | 7200 |
|
|
2019
Q1 | $19K | Buy |
2,700
+1,900
| +238% | +$11.2K | ﹤0.01% | 7001 |
|
|
2018
Q4 | $4K | Sell |
800
-4,600
| -85% | -$34.5K | ﹤0.01% | 7429 |
|
|
2018
Q3 | $54K | Buy |
5,400
+2,000
| +59% | +$20.6K | ﹤0.01% | 6470 |
|
|
2018
Q2 | $24K | Buy |
+3,400
| New | +$18.5K | ﹤0.01% | 6833 |
|
|
2018
Q1 | – | Sell |
-3,500
| Closed | -$15K | – | 7766 |
|
|
2017
Q4 | $15K | Buy |
3,500
+1,100
| +46% | +$4.84K | ﹤0.01% | 6882 |
|
|
2017
Q3 | $13K | Sell |
2,400
-6,600
| -73% | -$51K | ﹤0.01% | 6617 |
|
|
2017
Q2 | $105K | Buy |
9,000
+5,700
| +173% | +$84K | ﹤0.01% | 5310 |
|
|
2017
Q1 | $66K | Buy |
3,300
+2,200
| +200% | +$46.9K | ﹤0.01% | 5517 |
|
|
2016
Q4 | $26K | Buy |
+1,100
| New | +$28.2K | ﹤0.01% | 6432 |
|
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$1.63M | – | 8033 |
|
|
2015
Q3 | $1.63M | Hold |
50,000
| – | – | ﹤0.01% | 2642 |
|
|
2015
Q2 | $1.86M | Buy |
+50,000
| New | +$2M | ﹤0.01% | 2588 |
|
Citigroup's VSI Position: Q4 2019 in Review
Citigroup sold out of Vitamin Shoppe Inc. (VSI) in Q4 2019, closing a stake of 9,084 shares — an estimated $59K sold.
Citigroup first reported a position in VSI in Q2 2013 and held it in 26 quarters. The position peaked at $2.68M in Q1 2016. 0 funds tracked by Wall St. Rank hold VSI as of Q4 2019.
- Citigroup reported no remaining Vitamin Shoppe Inc. position as of Q4 2019 after selling out during the quarter.
- Citigroup sold 9,084 Vitamin Shoppe Inc. shares in Q4 2019, an estimated $59K.
- Citigroup first reported a position in Vitamin Shoppe Inc. in Q2 2013 and held it in 26 quarters.
- Citigroup's Vitamin Shoppe Inc. position peaked at $2.68M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Vitamin Shoppe Inc. as of Q4 2019.
Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.